The Headline That Shook the Aesthetic World
A story emerged from the Irish Examiner, a headline that spread through our community like wildfire: "Fillers may cause lymphatic blockage and possibly worse." For any clinician, this is a moment that tests your resolve. Your patients will come to you, anxious and uncertain, having read this article. They will ask if what you do is safe. And deep down, you might ask yourself the same question. This is a moment to step back, to examine the story not as a verdict, but as a conversation—a chance to reinforce the values and knowledge that guide your practice.
The research in question comes from a plastic surgeon named Spiro Theodoru. He conducted a study where he injected dye into tissues to observe how filler might affect lymphatic drainage. The idea was that if the dye did not leave the injected area, it meant the lymphatics were blocked. But is that really what the experiment shows? There is a difference between a dye that cannot leave because it is interacting with the hyaluronic acid in the filler and a true blockage of the lymphatic channels themselves. The dye may simply be held in place by the very molecule that gives filler its volume. That is not the same as a blocked lymphatic system. From there, the surgeon made a leap to suggest a global effect on the immune system—a leap that is not supported by the evidence presented. And then, in the same article, delayed onset nodules were thrown in as if they were part of the same problem, though they are not directly connected to lymphatic blockage at all.
When you read such articles, it is always wise to remember the commercial drivers. Scary statements get clicks. Clicks bring attention and revenue. The more you develop in your career, the more you recognize that the stories that dominate our attention often have a financial angle. That is not evil—it is just how the world works. But it should inform how you interpret the information.
What Is Really Happening with Under-Eye Filler?
The surgeon specifically targeted under-eye filler, calling it one of the biggest problems he sees. He spoke of women everywhere with swollen eyes, of young women having fillers that never go away, that block lymphatics. Let us unpack this. The skin under the eye is only two millimeters thick. If you inject a little too much, or if the filler breaks down slowly and attracts moisture, or if there is a genuine lymphatic issue, you will see a protrusion. It is visible, yes. But it is also treatable. Hyaluronidase can dissolve it quickly. The surgeon argued that complete removal is a significant challenge, but clinical experience shows that it is not that hard to reverse.
So, what is the real concern? Hyaluronic acid is a molecule that holds moisture. It is part of the extracellular matrix, just like collagen. Collagen sits in your skin and does not drain out through lymphatics—it stays put, providing structure. Hyaluronic acid does the same. It is not going anywhere dangerous; it simply supports the tissue. The question is whether fragments of hyaluronic acid can break off, enter the lymphatic system, and block it. This is theoretically possible. In mice, when you destroy the gene that produces hyaluronidase, the entire body becomes puffy because the lymphatic system fails. But that is a whole-body effect. With a small amount of filler injected into a localized area, what are the chances that intermediate fragments are actually blocking the lymphatics?
An alternative explanation is that the filler is simply holding onto moisture within the tissue, and the dye used in the study is interacting with the hyaluronic acid rather than testing lymphatic drainage. The dye might not drain because it is trapped in the gel, not because the channels are blocked. These are two very different scenarios. And even if there were localized blockage, would it pose a systemic threat? The lymphatic system filters debris through lymph nodes, and white blood cells can still reach tissues through the bloodstream. A local blockage might mean that an infection clears a little more slowly, but it is not a systemic immune failure. If the lymphatics were completely blocked, you would know—the face would become very puffy, and those patients require treatment anyway. In my experience, that is not a routine outcome. Some patients do experience puffiness over time, and it may be filler-specific, but it is not universal.
The Different Threads Woven into One Scary Story
To the untrained eye, the article blends several distinct risks into one alarming narrative. It mentions immune response, lymphatic blockage, and even cancer. These are separate issues. Let us break them down.
Immune Response and Delayed Onset Nodules
You mentioned that you once had a viral illness and woke up with your filler sites red and swollen. That is a real phenomenon. When your immune system is highly active, it can react to the filler as well. This is more common with fillers that contain short-chain hyaluronic acid, which is inflammatory. Long-chain hyaluronic acid is actually anti-inflammatory. The product you choose makes a difference. But this is not about lymphatic blockage—it is about an immune reaction that usually resolves on its own. It is a known risk, but it is not the same as a systemic immune failure.
Lymphatic Drainage vs. Systemic Immune Threat
The article tries to link filler to a compromised immune system. Dr. Patrick Treacy’s comment, which you shared, rightly points out that even if fillers block lymphatics locally, they do not pose a systemic threat to the immune system. The immune system is vast. White blood cells can still reach the area. It might be less efficient, but it is not destroyed. The real risk for patients is puffiness—what some call over-treatment syndrome. That is a minority outcome, and it is manageable.
The Cancer Connection
The article randomly brings up breast cancer in relation to a type of breast implant that caused inflammation. That is a completely different scenario. We are not seeing a wave of cheek cancers. The word “cancer” was thrown in to amplify fear, not because there is evidence linking facial fillers to malignancy. It is a tactic to stoke anxiety.
The Surgeon’s Stance: A Predictable Position
The surgeon behind the study announced he will no longer use fillers because of his findings. When someone draws a line like that, it sounds like they have reached an absolute truth. But in reality, everything in aesthetics is a balance of pros and cons. What will he do instead? The safest intervention is to do nothing, but that denies the patient the benefit. If he recommends surgery, we must remember that a high number of patients are miserable after surgery—far more than those who are unhappy with filler. It is easy for a surgeon to dismiss the technique he does not perform, especially when it is the most popular and accessible treatment. This trope is so common in aesthetic medicine: the surgeon who disdains non-surgical techniques. It is predictable, and it is not that interesting on its own. What matters is the actual reasoning and whether the alternative is truly safer.
What Clinicians Should Take Away
Moments like this are important. They test your ability to interpret new information in a balanced way. I have always carried a small fear that one day we will learn that something we have been injecting for years is harmful. But you must interpret these stories through a lens of proportionality. Scary things get disproportionately amplified. Your role as a clinician is to weigh the evidence, acknowledge both the risks and the benefits, and help patients make decisions in the context of their lives.
There are countless patients whose lives have been transformed by filler. They feel happier, more confident. Yes, a small number may end up looking a bit overtreated and need reversal or a pause. But there is no alternative path that is risk-free. Surgery has its own complications, and doing nothing leaves people struggling with the emotional impact of aging. It is messy. There is no clear, perfect path. A good clinician helps patients navigate that mess.
When new information comes out, do not take a strong position immediately. Instead, explain it from both sides. Instead of shouting “fillers last 12 years!” or “fillers block lymphatics!”, be the one who says: “Yes, there are risks, but there are benefits too. Let’s talk about them and find the best balance for you.” That is what a true professional does.
Different Fillers, Different Risks
It is also important to distinguish between types of fillers. Hyaluronic acid fillers are reversible and behave differently from non-reversible fillers like calcium hydroxyapatite (Radiesse) or poly-L-lactic acid (Sculptra). Calcium hydroxyapatite does not drain through lymphatics the same way, and it triggers collagen production. Sculptra stimulates a foreign body reaction that involves the immune system in a different manner—it causes fibroblasts to produce collagen. That collagen is not going to block lymphatics. But it can lead to lumps and nodules that may appear years later. That is the scary side: you might forget you had Sculptra, and then suddenly you feel bumps on your temple. Every clinician who loves Sculptra will say that doesn’t happen if you do it correctly, but it is a known risk. One day, an article will pop up about that, and everyone will panic. But again, it is a minority experience, and the treatment helps many others in the meantime. That is the complexity of medical decision-making. If it were black and white, you wouldn’t need a clinician at all.
A Final Reflection
When you receive new information like this, take the time to find the original source. This particular study is not even published yet, which is a major limitation. We don’t yet know whether the test is a valid measure of lymphatic drainage or simply a demonstration of how hyaluronic acid holds onto moisture. So, find the source. Then, interpret it within the context of the pros and cons. There is always something good about what we do and something bad. The balance is what matters, and it must be weighed against the risk of doing nothing—which for many people is a genuinely sad and painful prospect.
Do not be afraid to talk about these topics with your patients. The best clinicians never fob a patient off. They know a little more than the patient does, and they share that knowledge openly. That is how trust is built.
I hope this helps you navigate the conversation with confidence. See you next time.